CD39 expression defines cell exhaustion in tumor-infiltrating CD8+ T cells
- Autores
- Canale, Fernando Pablo; Ramello, María Cecilia; Nuñez, Nicolás; Araujo Furlan, Cintia Liliana; Bossio, Sabrina Noemí; Gorosito Serran, Melisa; Tosello Boari, Jimena; del Castillo, Andrés; Ledesma, Marta; Sedlik, Christine; Piaggio, Eliane; Gruppi, Adriana; Acosta Rodriguez, Eva Virginia; Montes, Carolina Lucia
- Año de publicación
- 2018
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- The ability of CD8+ T lymphocytes to eliminate tumors is limited by their ability to engender an immunosuppressive microenvironment. Here we describe a subset of tumor-infiltrating CD8+ T cells marked by high expression of the immunosuppressive ATP ectonucleotidase CD39. The frequency of CD39highCD8+ T cells increased with tumor growth but was absent in lymphoid organs. Tumor-infiltrating CD8+ T cells with high CD39 expression exhibited features of exhaustion, such as reduced production of TNF and IL2 and expression of coinhibitory receptors. Exhausted CD39+CD8+ T cells from mice hydrolyzed extracellular ATP, confirming that CD39 is enzymatically active. Furthermore, exhausted CD39+CD8+ T cells inhibited IFNg production by responderCD8+ T cells. In specimens from breast cancer and melanoma patients, CD39+CD8+ T cells were present within tumors and invaded or metastatic lymph nodes, but were barely detectable within noninvaded lymph nodes and absent in peripheral blood. These cells exhibited an exhausted phenotype with impaired production of IFNg, TNF, IL2, and high expression of coinhibitory receptors. Although T-cell receptor engagement was sufficient to induceCD39 on human CD8+ T cells, exposure to IL6 and IL27 promoted CD39 expression on stimulated CD8+ T cells from human or murine sources. Our findings show how the tumor microenvironment drives the acquisition of CD39 as an immune regulatory molecule onCD8+ T cells, withimplications for defining abiomarker of T-cell dysfunction and a target for immunotherapeutic intervention. Significance: The tumor microenvironment elicits a subset of functionally exhausted CD8+ T cells by creating conditions that induce cell surface expression of CD39, an immunosuppressive molecule that can be therapeutically targeted to restore effector T-cell function.
Fil: Canale, Fernando Pablo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina
Fil: Ramello, María Cecilia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina
Fil: Nuñez, Nicolás. Institute Curie. U-932 Immunity And Cancer; Francia
Fil: Araujo Furlan, Cintia Liliana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina
Fil: Bossio, Sabrina Noemí. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina
Fil: Gorosito Serran, Melisa. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina
Fil: Tosello Boari, Jimena. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina
Fil: del Castillo, Andrés. Hospital Rawson; Argentina
Fil: Ledesma, Marta. Hospital Rawson; Argentina
Fil: Sedlik, Christine. Institute Curie. U-932 Immunity And Cancer; Francia
Fil: Piaggio, Eliane. Institute Curie. U-932 Immunity And Cancer; Francia
Fil: Gruppi, Adriana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina
Fil: Acosta Rodriguez, Eva Virginia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina
Fil: Montes, Carolina Lucia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina - Materia
-
CD39
CD8 T CELL
EXHAUSTION
CANCER
IMMUNOREGULATION - Nivel de accesibilidad
- acceso embargado
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/50228
Ver los metadatos del registro completo
id |
CONICETDig_cd805118ec9b84184631dfd598732412 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/50228 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
CD39 expression defines cell exhaustion in tumor-infiltrating CD8+ T cellsCanale, Fernando PabloRamello, María CeciliaNuñez, NicolásAraujo Furlan, Cintia LilianaBossio, Sabrina NoemíGorosito Serran, MelisaTosello Boari, Jimenadel Castillo, AndrésLedesma, MartaSedlik, ChristinePiaggio, ElianeGruppi, AdrianaAcosta Rodriguez, Eva VirginiaMontes, Carolina LuciaCD39CD8 T CELLEXHAUSTIONCANCERIMMUNOREGULATIONhttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3The ability of CD8+ T lymphocytes to eliminate tumors is limited by their ability to engender an immunosuppressive microenvironment. Here we describe a subset of tumor-infiltrating CD8+ T cells marked by high expression of the immunosuppressive ATP ectonucleotidase CD39. The frequency of CD39highCD8+ T cells increased with tumor growth but was absent in lymphoid organs. Tumor-infiltrating CD8+ T cells with high CD39 expression exhibited features of exhaustion, such as reduced production of TNF and IL2 and expression of coinhibitory receptors. Exhausted CD39+CD8+ T cells from mice hydrolyzed extracellular ATP, confirming that CD39 is enzymatically active. Furthermore, exhausted CD39+CD8+ T cells inhibited IFNg production by responderCD8+ T cells. In specimens from breast cancer and melanoma patients, CD39+CD8+ T cells were present within tumors and invaded or metastatic lymph nodes, but were barely detectable within noninvaded lymph nodes and absent in peripheral blood. These cells exhibited an exhausted phenotype with impaired production of IFNg, TNF, IL2, and high expression of coinhibitory receptors. Although T-cell receptor engagement was sufficient to induceCD39 on human CD8+ T cells, exposure to IL6 and IL27 promoted CD39 expression on stimulated CD8+ T cells from human or murine sources. Our findings show how the tumor microenvironment drives the acquisition of CD39 as an immune regulatory molecule onCD8+ T cells, withimplications for defining abiomarker of T-cell dysfunction and a target for immunotherapeutic intervention. Significance: The tumor microenvironment elicits a subset of functionally exhausted CD8+ T cells by creating conditions that induce cell surface expression of CD39, an immunosuppressive molecule that can be therapeutically targeted to restore effector T-cell function.Fil: Canale, Fernando Pablo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; ArgentinaFil: Ramello, María Cecilia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; ArgentinaFil: Nuñez, Nicolás. Institute Curie. U-932 Immunity And Cancer; FranciaFil: Araujo Furlan, Cintia Liliana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; ArgentinaFil: Bossio, Sabrina Noemí. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; ArgentinaFil: Gorosito Serran, Melisa. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; ArgentinaFil: Tosello Boari, Jimena. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; ArgentinaFil: del Castillo, Andrés. Hospital Rawson; ArgentinaFil: Ledesma, Marta. Hospital Rawson; ArgentinaFil: Sedlik, Christine. Institute Curie. U-932 Immunity And Cancer; FranciaFil: Piaggio, Eliane. Institute Curie. U-932 Immunity And Cancer; FranciaFil: Gruppi, Adriana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; ArgentinaFil: Acosta Rodriguez, Eva Virginia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; ArgentinaFil: Montes, Carolina Lucia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; ArgentinaAmerican Association for Cancer Research2018-01-24info:eu-repo/date/embargoEnd/2018-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/50228Canale, Fernando Pablo; Ramello, María Cecilia; Nuñez, Nicolás; Araujo Furlan, Cintia Liliana; Bossio, Sabrina Noemí; et al.; CD39 expression defines cell exhaustion in tumor-infiltrating CD8+ T cells; American Association for Cancer Research; Cancer Research; 78; 1; 24-1-2018; 115-1280008-54721538-7445CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/http://cancerres.aacrjournals.org/lookup/doi/10.1158/0008-5472.CAN-16-2684info:eu-repo/semantics/altIdentifier/doi/10.1158/0008-5472.CAN-16-2684info:eu-repo/semantics/altIdentifier/url/http://cancerres.aacrjournals.org/content/78/1/115info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pubmed/29066514info:eu-repo/semantics/embargoedAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:46:46Zoai:ri.conicet.gov.ar:11336/50228instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:46:46.542CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
CD39 expression defines cell exhaustion in tumor-infiltrating CD8+ T cells |
title |
CD39 expression defines cell exhaustion in tumor-infiltrating CD8+ T cells |
spellingShingle |
CD39 expression defines cell exhaustion in tumor-infiltrating CD8+ T cells Canale, Fernando Pablo CD39 CD8 T CELL EXHAUSTION CANCER IMMUNOREGULATION |
title_short |
CD39 expression defines cell exhaustion in tumor-infiltrating CD8+ T cells |
title_full |
CD39 expression defines cell exhaustion in tumor-infiltrating CD8+ T cells |
title_fullStr |
CD39 expression defines cell exhaustion in tumor-infiltrating CD8+ T cells |
title_full_unstemmed |
CD39 expression defines cell exhaustion in tumor-infiltrating CD8+ T cells |
title_sort |
CD39 expression defines cell exhaustion in tumor-infiltrating CD8+ T cells |
dc.creator.none.fl_str_mv |
Canale, Fernando Pablo Ramello, María Cecilia Nuñez, Nicolás Araujo Furlan, Cintia Liliana Bossio, Sabrina Noemí Gorosito Serran, Melisa Tosello Boari, Jimena del Castillo, Andrés Ledesma, Marta Sedlik, Christine Piaggio, Eliane Gruppi, Adriana Acosta Rodriguez, Eva Virginia Montes, Carolina Lucia |
author |
Canale, Fernando Pablo |
author_facet |
Canale, Fernando Pablo Ramello, María Cecilia Nuñez, Nicolás Araujo Furlan, Cintia Liliana Bossio, Sabrina Noemí Gorosito Serran, Melisa Tosello Boari, Jimena del Castillo, Andrés Ledesma, Marta Sedlik, Christine Piaggio, Eliane Gruppi, Adriana Acosta Rodriguez, Eva Virginia Montes, Carolina Lucia |
author_role |
author |
author2 |
Ramello, María Cecilia Nuñez, Nicolás Araujo Furlan, Cintia Liliana Bossio, Sabrina Noemí Gorosito Serran, Melisa Tosello Boari, Jimena del Castillo, Andrés Ledesma, Marta Sedlik, Christine Piaggio, Eliane Gruppi, Adriana Acosta Rodriguez, Eva Virginia Montes, Carolina Lucia |
author2_role |
author author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
CD39 CD8 T CELL EXHAUSTION CANCER IMMUNOREGULATION |
topic |
CD39 CD8 T CELL EXHAUSTION CANCER IMMUNOREGULATION |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
The ability of CD8+ T lymphocytes to eliminate tumors is limited by their ability to engender an immunosuppressive microenvironment. Here we describe a subset of tumor-infiltrating CD8+ T cells marked by high expression of the immunosuppressive ATP ectonucleotidase CD39. The frequency of CD39highCD8+ T cells increased with tumor growth but was absent in lymphoid organs. Tumor-infiltrating CD8+ T cells with high CD39 expression exhibited features of exhaustion, such as reduced production of TNF and IL2 and expression of coinhibitory receptors. Exhausted CD39+CD8+ T cells from mice hydrolyzed extracellular ATP, confirming that CD39 is enzymatically active. Furthermore, exhausted CD39+CD8+ T cells inhibited IFNg production by responderCD8+ T cells. In specimens from breast cancer and melanoma patients, CD39+CD8+ T cells were present within tumors and invaded or metastatic lymph nodes, but were barely detectable within noninvaded lymph nodes and absent in peripheral blood. These cells exhibited an exhausted phenotype with impaired production of IFNg, TNF, IL2, and high expression of coinhibitory receptors. Although T-cell receptor engagement was sufficient to induceCD39 on human CD8+ T cells, exposure to IL6 and IL27 promoted CD39 expression on stimulated CD8+ T cells from human or murine sources. Our findings show how the tumor microenvironment drives the acquisition of CD39 as an immune regulatory molecule onCD8+ T cells, withimplications for defining abiomarker of T-cell dysfunction and a target for immunotherapeutic intervention. Significance: The tumor microenvironment elicits a subset of functionally exhausted CD8+ T cells by creating conditions that induce cell surface expression of CD39, an immunosuppressive molecule that can be therapeutically targeted to restore effector T-cell function. Fil: Canale, Fernando Pablo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina Fil: Ramello, María Cecilia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina Fil: Nuñez, Nicolás. Institute Curie. U-932 Immunity And Cancer; Francia Fil: Araujo Furlan, Cintia Liliana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina Fil: Bossio, Sabrina Noemí. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina Fil: Gorosito Serran, Melisa. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina Fil: Tosello Boari, Jimena. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina Fil: del Castillo, Andrés. Hospital Rawson; Argentina Fil: Ledesma, Marta. Hospital Rawson; Argentina Fil: Sedlik, Christine. Institute Curie. U-932 Immunity And Cancer; Francia Fil: Piaggio, Eliane. Institute Curie. U-932 Immunity And Cancer; Francia Fil: Gruppi, Adriana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina Fil: Acosta Rodriguez, Eva Virginia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina Fil: Montes, Carolina Lucia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina |
description |
The ability of CD8+ T lymphocytes to eliminate tumors is limited by their ability to engender an immunosuppressive microenvironment. Here we describe a subset of tumor-infiltrating CD8+ T cells marked by high expression of the immunosuppressive ATP ectonucleotidase CD39. The frequency of CD39highCD8+ T cells increased with tumor growth but was absent in lymphoid organs. Tumor-infiltrating CD8+ T cells with high CD39 expression exhibited features of exhaustion, such as reduced production of TNF and IL2 and expression of coinhibitory receptors. Exhausted CD39+CD8+ T cells from mice hydrolyzed extracellular ATP, confirming that CD39 is enzymatically active. Furthermore, exhausted CD39+CD8+ T cells inhibited IFNg production by responderCD8+ T cells. In specimens from breast cancer and melanoma patients, CD39+CD8+ T cells were present within tumors and invaded or metastatic lymph nodes, but were barely detectable within noninvaded lymph nodes and absent in peripheral blood. These cells exhibited an exhausted phenotype with impaired production of IFNg, TNF, IL2, and high expression of coinhibitory receptors. Although T-cell receptor engagement was sufficient to induceCD39 on human CD8+ T cells, exposure to IL6 and IL27 promoted CD39 expression on stimulated CD8+ T cells from human or murine sources. Our findings show how the tumor microenvironment drives the acquisition of CD39 as an immune regulatory molecule onCD8+ T cells, withimplications for defining abiomarker of T-cell dysfunction and a target for immunotherapeutic intervention. Significance: The tumor microenvironment elicits a subset of functionally exhausted CD8+ T cells by creating conditions that induce cell surface expression of CD39, an immunosuppressive molecule that can be therapeutically targeted to restore effector T-cell function. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-01-24 info:eu-repo/date/embargoEnd/2018-08-01 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/50228 Canale, Fernando Pablo; Ramello, María Cecilia; Nuñez, Nicolás; Araujo Furlan, Cintia Liliana; Bossio, Sabrina Noemí; et al.; CD39 expression defines cell exhaustion in tumor-infiltrating CD8+ T cells; American Association for Cancer Research; Cancer Research; 78; 1; 24-1-2018; 115-128 0008-5472 1538-7445 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/50228 |
identifier_str_mv |
Canale, Fernando Pablo; Ramello, María Cecilia; Nuñez, Nicolás; Araujo Furlan, Cintia Liliana; Bossio, Sabrina Noemí; et al.; CD39 expression defines cell exhaustion in tumor-infiltrating CD8+ T cells; American Association for Cancer Research; Cancer Research; 78; 1; 24-1-2018; 115-128 0008-5472 1538-7445 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/http://cancerres.aacrjournals.org/lookup/doi/10.1158/0008-5472.CAN-16-2684 info:eu-repo/semantics/altIdentifier/doi/10.1158/0008-5472.CAN-16-2684 info:eu-repo/semantics/altIdentifier/url/http://cancerres.aacrjournals.org/content/78/1/115 info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pubmed/29066514 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/embargoedAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
embargoedAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
American Association for Cancer Research |
publisher.none.fl_str_mv |
American Association for Cancer Research |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842268815365242880 |
score |
13.13397 |